PO.MCB02.02 · 分子与细胞生物学

石棉暴露通过少数MOMP诱导癌变并表现出耐药持留细胞的特征

Asbestos exposure induces carcinogenesis via minority MOMP and displays characteristics of drug-tolerant persister cells

编号 554 展板 6 时间 4/19 02:00–05:00 区域 Section 23 主讲 Jaylon Aggison, BS
分会场 Targeting Mitochondria and Metabolic Vulnerabilities for Cancer Therapy
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Jaylon C. Aggison, Cristian G. Medina, Siqi Wu, Naren Li, Francisco A. Molina-Pelayo, Jessica B. Ji, Ritika Raj, Yuan Xu, Robert Taylor Ripley

Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX

摘要 Abstract

中文摘要
背景:胸膜间皮瘤(PM)在石棉纤维暴露多年后发生;然而将慢性损伤转化为恶性肿瘤的机制仍不清楚。石棉纤维诱导持续的氧化和基因组应激,这本应通过线粒体外膜通透化(MOMP)激活凋亡;然而这些细胞并不发生凋亡,反而发展为恶性肿瘤。MOMP通常触发细胞色素c(cyt c)释放以及线粒体来源的损伤相关分子模式(DAMPs),导致caspase活化和细胞死亡。MOMP的亚致死性激活可导致一种称为不完全或少数MOMP(Minority MOMP)的现象,其中细胞存活并产生促进癌变的体细胞突变。本研究中,我们评估了少数MOMP是否在PM细胞中诱导癌变。 方法:我们研究了长期暴露于石棉纤维是否驱动非转化的胸膜间皮细胞(MeT-5A)中的少数MOMP。将细胞与温石棉(Chry-Asb)或青石棉(Croc-Asb)石棉纤维培养六个月。通过克隆形成、迁移和侵袭实验评估细胞表型以评价恶性转化。测定活性氧(ROS)产生、细胞色素c(cyt c)释放、gammaH2AX磷酸化和caspase 3活化,以评价线粒体和凋亡反应。 结果:慢性石棉暴露增加了MeT-5A细胞的克隆形成能力、迁移和侵袭,提示向恶性表型转化。此外,我们观察到少数MOMP的表型特征,包括ROS升高、cyt c释放、MOMP效应蛋白(Bax/Bak)增加、caspase活化和gammaH2AX磷酸化,而缺乏凋亡诱导。此外,抗凋亡线粒体蛋白髓细胞白血病-1(MCL-1)被石棉上调,通过阻止向完全MOMP转变而促进少数MOMP。代谢组学分析揭示了Warburg效应。与Warburg效应一致,Seahorse分析和基因集富集分析均显示两株细胞系中糖酵解增加。此外,石棉诱导的少数MOMP与耐药持留细胞(DTPs)的特征相关,包括增殖减慢、细胞表型改变和对顺铂的耐药。 结论:少数MOMP促进间皮细胞的恶性转化,同时使其能够抵抗凋亡。我们的发现提示,少数MOMP通过改变线粒体动力学和代谢重编程促进癌变,将细胞重编程为DTP表型。靶向线粒体通路以将少数MOMP转化为完全MOMP,可能代表一种克服胸膜间皮瘤治疗耐药的新型治疗策略。
查看英文原文 English abstract
Background Pleural mesothelioma (PM) occurs many years after asbestos fiber exposure; yet the mechanism that converts chronic damage into malignancy remains unclear. Asbestos fibers induce persistent oxidative and genomic stress that should activate apoptosis via mitochondrial outer membrane permeabilization (MOMP); however, these cells do not undergo apoptosis and instead develop into malignancy. MOMP normally triggers cytochrome c (cyt c) release as well as mitochondrially derived damage-associated molecular patterns (DAMPs), resulting in caspase activation and cell death. Sublethal activation of MOMP can lead to a phenomenon known as Incomplete or Minority mMOMP, in which cells survive and develop somatic mutations which contribute to carcinogenesis. In this study, we evaluated whether minority MOMP induced carcinogenesis in PM cells. Methods We investigated whether prolonged exposure to asbestos fibers drives mMOMP in non-transformed, pleural mesothelial cells (MeT-5A). Cells were cultured for six months with chrysotile (Chry-Asb) or crocidolite (Croc-Asb) asbestos fibers. Cellular phenotypes were assessed by clonogenicity, migration, and invasion assays to evaluate malignant transformation. Reactive oxygen species (ROS) production, cytochrome (cyt) c release, gammaH2AX phosphorylation, and caspase 3 activation were measured to evaluate mitochondrial and apoptotic responses. Results Chronic asbestos exposure increased clonogenicity, migration, and invasion of MeT-5A cells, suggesting transformation toward a malignant phenotype. Additionally, we observed the phenotypic characteristics of minority MOMP, including elevated ROS, cyt c release, an increase in the MOMP effector proteins (Bax/Bak), caspase activation, and gammaH2AX phosphorylation while lacking induction of apoptosis. Furthermore, the anti-apoptotic mitochondrial protein Myeloid Cell Leukemia-1 (MCL-1) was upregulated by asbestos, facilitating minority MOMP by preventing a shift to complete MOMP. Metabolomic analysis revealed a Warburg effect. Consistent with the Warburg effect, both Seahorse analysis and Gene Set Enrichment Analysis showed increased glycolysis in both cell lines. Additionally, asbestos-induced minority MOMP was associated with characteristics of drug-tolerant persister cells (DTPs) including slower proliferation, change in cell phenotype, and resistance to cisplatin. Conclusion Minority MOMP promotes malignant transformation of mesothelial cells while enabling resistance to apoptosis. Our findings suggest that minority MOMP contributes to carcinogenesis by altering mitochondrial dynamics and metabolic reprogramming, reprogramming cells to a DTP phenotype. Targeting mitochondrial pathways to convert Minority MOMP into complete MOMP may represent a novel therapeutic strategy to overcome treatment resistance in pleural mesothelioma.
利益披露 Disclosure
J. C. Aggison, None.. C. G. Medina, None.. S. Wu, None.. N. Li, None.. F. A. Molina-Pelayo, None.. J. B. Ji, None.. R. Raj, None.. Y. Xu, None.. R. T. Ripley, None.

← 返回 AACR 2026 检索